Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China's National Medical Products Administration (NMPA)
Pharma
Roche's answer to AstraZeneca PNH drugs nabs China nod
China has become the first country to sign off on Roche’s PNH drug crovalimab, a subcutaneous answer to AZ’s infused treatments Soliris and Ultomiris.
Kevin Dunleavy
Feb 8, 2024 11:02am
China suspends GSK from bulk-buy program through April 2024
Oct 31, 2022 10:51am
Bayer, Hua snag first-in-class diabetes nod for Roche castoff
Oct 10, 2022 10:40am
UCB’s anti-seizure drug suspended by Chinese regulators
Aug 24, 2022 9:55am
In a first, China approves eye implant based solely on RWD
Jun 21, 2022 11:22am
Chinese firms win subcutaneous checkpoint inhibitor approval
Nov 30, 2021 9:15am